UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In-situ scalable manufacturing of Epstein-Barr virus-specific T-cells using bioreactor with an expandable culture area (BECA)

Scientific reports, 2022-04, Vol.12 (1), p.7045-7045, Article 7045

2022

Volltextzugriff (PDF)

A phase I study of an adenoviral vector delivering a MUC1/CD40-ligand fusion protein in patients with advanced adenocarcinoma

Nature communications, 2022-10, Vol.13 (1), p.6453-11, Article 6453

2022

Volltextzugriff (PDF)

A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs)

Cancers, 2020-11, Vol.12 (11), p.3404

2020

Volltextzugriff (PDF)

TCR repertoire characteristics predict clinical response to adoptive CTL therapy against nasopharyngeal carcinoma

Oncoimmunology, 2021-01, Vol.10 (1), p.1955545-1955545

2021

Volltextzugriff (PDF)

Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma

PloS one, 2013-07, Vol.8 (7), p.e68904-e68904

2013

Volltextzugriff (PDF)

Tailoring precision immunotherapy: coming to a clinic soon?

ESMO open, 2020, Vol.5 (Suppl 1), p.e000631-e000631, Article e000631

2020

Volltextzugriff (PDF)

Clinical Benefit of Allogeneic Melanoma Cell Lysate–Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients

Clinical cancer research, 2009-12, Vol.15 (24), p.7726-7736

2009

Volltextzugriff (PDF)

Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma

Molecular therapy, 2014-01, Vol.22 (1), p.132-139

2014

Volltextzugriff (PDF)

Monocytic Myeloid-Derived Suppressor Cells Underpin Resistance to Adoptive T Cell Therapy in Nasopharyngeal Carcinoma

Molecular therapy, 2021-02, Vol.29 (2), p.734-743

2021

Volltextzugriff (PDF)

Coriolus versicolor (Yunzhi) Use as Therapy in Advanced Hepatocellular Carcinoma Patients with Poor Liver Function or Who Are Unfit for Standard Therapy

The journal of alternative and complementary medicine (New York, N.Y.), 2017-08, Vol.23 (8), p.648-652

2017

Volltextzugriff (PDF)

Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detection

Scientific reports, 2016-02, Vol.6 (1), p.20299, Article 20299

2016

Volltextzugriff (PDF)

P851 Identifying potential predictive biomarkers from plasma exosomes and adoptive T cells that differentiate short and long-term metastatic nasopharyngeal cancer survivors treated with chemotherapy and virus-specific T cells

Journal for immunotherapy of cancer, 2020-04, Vol.8 (Suppl 1), p.A3-A4

2020

Volltextzugriff (PDF)

Cancer Immunotherapy - The Target is Precisely on The Cancer and Also Not

Annals of the Academy of Medicine, Singapore, 2018-09, Vol.47 (9), p.381-387

2018

Volltextzugriff (PDF)

First-in-man study of Ad-sig-hMUC1/ecdCD40L vaccine for immunotherapy of MUC1 overexpressing epithelial cancers

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.3098-3098

2018

Volltextzugriff (PDF)

Cellular immune biomarkers to prognosticate for survival to adoptive T-cell therapy in advanced nasopharyngeal cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.6047-6047

2017

Volltextzugriff (PDF)

Ex vivo co-culture models for immunotherapy with patient-derived tumor infiltrating lymphocytes, peripheral blood mononuclear cells and autologous patient colorectal cancer (CRC) cell lines

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e15531-e15531

2018

Volltextzugriff (PDF)

Abstract 1654: Immune repertoire amongst subpopulations of tumor infiltrating lymphocytes (TILs) in colorectal cancer: Oligoclonality is predominantly observed in cytotoxic CD8+ TILs

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1654-1654

2014

Volltextzugriff (PDF)

Defining precision cellular immunotherapy—seeking biomarkers to predict and optimize outcomes of T cell therapies in cancer

Precision Cancer Medicine, 2019-08, Vol.2, p.25-25

2019

Volltextzugriff (PDF)

Characterisation of the Murine 5T4 Oncofoetal Antigen

Wang, Who-Whong

2003

Volltextzugriff (PDF)

Cancer Immunotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma, 2019

2019

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(16)

Publikationsform

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

In-situ scalable manufacturing of Epstein-Barr virus-specific T-cells using bioreactor with an expandable culture area (BECA)

A phase I study of an adenoviral vector delivering a MUC1/CD40-ligand fusion protein in patients with advanced adenocarcinoma

A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs)

TCR repertoire characteristics predict clinical response to adoptive CTL therapy against nasopharyngeal carcinoma

Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma

Tailoring precision immunotherapy: coming to a clinic soon?

Clinical Benefit of Allogeneic Melanoma Cell Lysate–Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients

Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma

Monocytic Myeloid-Derived Suppressor Cells Underpin Resistance to Adoptive T Cell Therapy in Nasopharyngeal Carcinoma

Coriolus versicolor (Yunzhi) Use as Therapy in Advanced Hepatocellular Carcinoma Patients with Poor Liver Function or Who Are Unfit for Standard Therapy

Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detection

P851 Identifying potential predictive biomarkers from plasma exosomes and adoptive T cells that differentiate short and long-term metastatic nasopharyngeal cancer survivors treated with chemotherapy and virus-specific T cells

Cancer Immunotherapy - The Target is Precisely on The Cancer and Also Not

First-in-man study of Ad-sig-hMUC1/ecdCD40L vaccine for immunotherapy of MUC1 overexpressing epithelial cancers

Cellular immune biomarkers to prognosticate for survival to adoptive T-cell therapy in advanced nasopharyngeal cancer

Ex vivo co-culture models for immunotherapy with patient-derived tumor infiltrating lymphocytes, peripheral blood mononuclear cells and autologous patient colorectal cancer (CRC) cell lines

Abstract 1654: Immune repertoire amongst subpopulations of tumor infiltrating lymphocytes (TILs) in colorectal cancer: Oligoclonality is predominantly observed in cytotoxic CD8+ TILs

Defining precision cellular immunotherapy—seeking biomarkers to predict and optimize outcomes of T cell therapies in cancer

Characterisation of the Murine 5T4 Oncofoetal Antigen

Cancer Immunotherapy for Nasopharyngeal Carcinoma

Suchergebnisse filtern